However, Sun et al.106 showed that ARID1A has two opposing functions that are dependent on the timeline of HCC progression and that ARID1A promotes tumor initiation during the early stage by increasing the oxidative stress response but suppresses tumor metastasis and invasion in the late stage. The gene discussed is ARID1A; the disease is hepatocellular carcinoma.